COMPOSITION FOR DIAGNOSING NEUROLOGICAL DISEASE USING NASAL MUCUS

摘要

The present invention relates to a composition for diagnosing neurological diseases comprising pharmaceutical preparation for measuring an expression level of beta amyloid oligomer in a separated nasal mucus sample, to a diagnosis kit for the neurological diseases, and to a method for detecting beta amyloid oligomer from the nasal mucus sample. In addition, the present invention relates to a screening method of medicine for neurological diseases comprising a step of measuring change of the expression level of the beta amyloid oligomer.